Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Open-market sale Director sold 3,082 shares at $54.15 ($166,884)
  2. 4 Open-market sale Director sold 5,153 shares at $60.00 ($309,180)
  3. 4 Open-market sale Director sold 1,509 shares at $56.12 ($84,692)
  4. 4 Shares withheld for taxes EVP, Corp Dev, GC & Secretary gave up 1,287 shares (to pay taxes)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Director sold 1,376 shares at $43.39 ($59,702)
  7. 4 Grant or award Director acquired 5,736 shares (grant or award)
  8. 4 Grant or award Director acquired 5,736 shares (grant or award)
  9. 4 Grant or award Director acquired 5,736 shares (grant or award)
  10. 4 Grant or award Director acquired 5,736 shares (grant or award)
  11. 4 Grant or award Director acquired 5,736 shares (grant or award)
  12. 4 Grant or award Director acquired 5,736 shares (grant or award)
  13. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 759 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP, Chief HR Officer gave up 237 shares (to pay taxes)
  15. 4 Shares withheld for taxes President and CEO gave up 95 shares (to pay taxes)
  16. 4 Exercise or conversion Director acquired 7,893 shares (option exercise)
  17. 4 Grant or award Director acquired 7,569 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale EVP, Business Operations sold 2,430 shares at $56.93 ($138,340)
  20. 4 Open-market sale EVP, Business Operations sold 3,043 shares at an average $58.11 ($176,819)

Page 17 of 49 · 970 filings